FDA Inspection 1035441 — Jubilant Draximage Inc.
The FDA completed an inspection of Jubilant Draximage Inc. on September 8, 2017 in Kirkland. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 8, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kirkland (Canada)